TLPH
TLPH clinical trials: TALPHERA, INC.
Every trial on ClinicalTrials.gov where TALPHERA, INC. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 18
- Trials linked
- 18
- As lead sponsor
- 0
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
TLPH on the catalyst calendar · TLPH registry changes
- Primary completion Dec 2025Sponsor estimateNo phase registeredNCT06150742Nafamostat Efficacy in Phase 3 Registrational CRRT StudyTalphera, Inc · Acute Kidney InjuryUnknown statusTLPHLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 14, 2017ActualPhase 3NCT02662764Study to Evaluate the Overall Performance of the Zalviso System™ (Sufentanil Sublingual Tablet System) 15 mcgTalphera, Inc · Moderate-to-severe Acute PainCompletedTLPHLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 2014ActualPhase 1NCT02082236Pharmacokinetics of Sufentanil Sublingual Microtablet 30 mcg and 15 mcg in Healthy SubjectsTalphera, Inc · HealthyCompletedTLPHLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 2016ActualPhase 3NCT02447848Open-Label Safety and Efficacy of the Sufentanil Sublingual Tablet 30 mcg for Acute PainTalphera, Inc · Moderate-to-severe Acute PainCompletedTLPHLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 2016ActualPhase 3NCT02662556A Multicenter, Open-Label Trial to Evaluate the Safety and Efficacy of the Sufentanil Sublingual Tablet 30 mcg in Patients With...Talphera, Inc · Acute Moderate-to-severe PainCompletedTLPHLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 2015ActualPhase 3NCT02356588A Trial Evaluating the Efficacy and Safety of the Sublingual Sufentanil Tablet 30 mcg for Post-Operative Pain After Abdominal SurgeryTalphera, Inc · Post-Operative PainCompletedTLPHLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2012ActualPhase 1NCT01721070Effect of Ketoconazole on Sufentanil NanoTab PharmacokineticsTalphera, Inc · PharmacokineticsCompletedTLPHLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 2013ActualPhase 3NCT01660763Efficacy and Safety Trial to Evaluate the Sufentanil NanoTab® PCA System/15 mcg (Zalviso™) for Post-Operative Pain in Patients After...Talphera, Inc · Post Operative PainCompletedTLPHLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 2013ActualPhase 3NCT01539642A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of the Sufentanil NanoTab PCA...Talphera, Inc · Post-Operative PainCompletedTLPHLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 2013ActualPhase 1NCT01761565Single and Multiple Dose Pharmacokinetics of Sufentanil NanoTabTalphera, Inc · Plasma ConcentrationsCompletedTLPHLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 2012ActualPhase 1NCT01639729Effect of Delivery Route on PK of Sufentanil NanoTabTalphera, Inc · PharmacokineticsCompletedTLPHLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2012ActualPhase 3NCT01539538A Multicenter, Randomized, Open-Label, Parallel-Group Trial to Compare the Efficacy and Safety of the Sufentanil NanoTab PCA System/15...Talphera, Inc · Post-Operative PainCompletedTLPHLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 2013ActualPhase 2NCT01710345Safety and Efficacy of Sufentanil NanoTab for Management of Acute Pain Following BunionectomyTalphera, Inc · Acute PainCompletedTLPHLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 2010ActualPhase 2NCT00833040A Study for the Evaluation of the Safety, Tolerability, and Efficacy of ARX-F02 (Sufentanil NanoTab) Compared to Placebo in the...Talphera, Inc · CancerCompletedTLPHLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 2009ActualPhase 2NCT00718081A Multicenter, Randomized, Placebo-Controlled Phase 2 Study to Evaluate the Clinical Efficacy, Safety, and Tolerability of ARX-F01...Talphera, Inc · Major Upper or Lower Abdominal SurgeryCompletedTLPHLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 2009ActualPhase 2NCT00894699A Study to Evaluate the Clinical Efficacy, Safety and Tolerability of ARX-F03 Sublingual Sufentanil/Triazolam NanoTab™ in Patients...Talphera, Inc · SedationCompletedTLPHLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 2008ActualPhase 2NCT00612534A Multicenter, Randomized, Placebo-Controlled Phase 2 Study to Evaluate the Clinical Efficacy, Safety, and Tolerability of ARX-F01...Talphera, Inc · Post Operative PainCompletedTLPHLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 2009ActualPhase 2NCT00859313An Open-Label Functionality, Safety and Efficacy Study in Patients Undergoing Elective Unilateral Knee ReplacementTalphera, Inc · Pain, PostoperativeCompletedTLPHLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 18 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner